pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

5,071 catalysts · 4,779 phase readout · 2,339 8k filing · 286 earnings · 271 pdufa · 166 phase 2 completion · 71 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-20: 0 catalysts2026-07-21: 0 catalysts2026-07-22: 0 catalysts2026-07-23: 0 catalysts2026-07-24: 1 catalyst2026-07-25: 0 catalysts2026-07-26: 0 catalysts2026-07-27: 2 catalysts2026-07-28: 4 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: earnings×type: filing×type: phase readout×clear all
type
  • phase readout4,779
  • 8k filing2,339
  • earnings286
  • pdufa271
  • phase 2 completion166
  • phase 1 completion71
phase 2 initiation
54
  • phase 1 initiation39
  • phase 1 2 completion33
  • phase 0 trial completion23
  • therapy area
    • Ophthalmology5

    Date TBD

    50
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04401748: Study Of Venetoclax Tablet With Intravenous or Subcutaneous Azacitidine to Assess Change in Disease Activity In Adult Participants With Newly Diagnosed Higher-Risk Myelodysplastic Syndrome

    Sponsor: AbbVie. Phase: PHASE3. Conditions: Myelodysplastic Syndrome (MDS)

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07347548: A Trial to Investigate the Safety and Pharmacokinetics of GRT6019 in Healthy Male Participants

    Sponsor: Grünenthal GmbH. Phase: PHASE1. Conditions: Duchenne Muscular Dystrophy (DMD)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05791448: AU409 for the Treatment of Advanced Primary Liver Cancers or Solid Tumor With Liver Metastatic Disease

    Sponsor: University of Southern California. Phase: PHASE1. Conditions: Advanced Cholangiocarcinoma, Advanced Hepatocellular Carcinoma, Advanced Malignant Solid Neoplasm, Metastatic Malignant Neoplasm in the Liver, Refractory Malignant Solid Neoplasm, Stage III Hepatocellular Carcinoma AJCC v8, Stage IV Hepatocellular Carcinoma AJCC v8

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07518043: A Study of HLX18 vs. OPDIVO® in Multiple Resected Solid Tumors

    Sponsor: Shanghai Henlius Biotech. Phase: PHASE1. Conditions: Esophageal and/or Cardia Cancer, Melanoma, Urothelial Carcinoma (UC)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07264426: Real-World Efgartigimod Effectiveness in CIDP: A Prospective Study

    Sponsor: argenx. Phase: . Conditions: Chronic Inflammatory Demyelinating Polyradiculoneuropathy, CIDP, CIDP (Chronic Inflammatory Demyelinating Polyradiculoneuropathy)

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07501143: Effects of Physical Training in Patients With Advanced Heart Failure

    Sponsor: University of Nove de Julho. Phase: NA. Conditions: Insuficiência Cardíaca, Transplante Cardíaco, Exercício Físico

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04722835: Lung Macrophage Populations and Functions in Chronic Obstructive Pulmonary Disease (COPD)-Susceptible Smokers

    Sponsor: University of California, San Francisco. Phase: . Conditions: Copd, Smoking, Tobacco Use

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04738708: Telegenetics or In-Person Genetic Counselling

    Sponsor: National Cancer Centre, Singapore. Phase: . Conditions: Genetic Counselling

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05458908: ProSPective Evaluation of Non-contrast sINe spiN Flat-dEtectoR CT for the Detection of Intracranial hemorrhageS

    Sponsor: University Hospital, Basel, Switzerland. Phase: NA. Conditions: Stroke

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07526376: Unstable Core Training in Air Pistol Athletes

    Sponsor: Shanghai University of Sport. Phase: NA. Conditions: Postural Stability, Motor Control, Sports Performance

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07380776: Preoperative Education Program on Gastrointestinal Quality of Life in Cholecystectomy Patients

    Sponsor: Hawler Medical University. Phase: NA. Conditions: Preoperative Patient Education , Quality of Life , Cholecystectomy

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06683040: Evaluation of the Efficacy and Safety of Oxacom® in Patients With Pulmonary Arterial Hypertension

    Sponsor: National Medical Research Center for Cardiology, Ministry of Health of Russian Federation. Phase: PHASE2. Conditions: Pulmonary Arterial Hypertension

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06601140: Evaluation of the Concordance Between Measures Obtained by a Medical Device for Emotional Monitoring (EMOCARE) and the Patient Health Questionnaire (PHQ-9) Score in Patients With Mild to Severe Depressive Episode

    Sponsor: Emobot. Phase: NA. Conditions: Major Depressive Disorder (MDD)

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07011940: Walk With Me (WWM) for Perinatal Grief

    Sponsor: Oregon Research Behavioral Intervention Strategies, Inc.. Phase: NA. Conditions: Grief, Post Traumatic Stress Disorder, Suicidal Ideation, Miscarriage, Stillbirth, Infant Death

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07509268: Assessment of the Clinical, Cellular and Molecular Effects of Royalactin-Royal Jelly on the Healing of Wagner Grad II Diabetic Foot Ulcers.

    Sponsor: Universidad Autonoma de Nuevo Leon. Phase: PHASE2. Conditions: Diabetic Foot Ulcer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07446491: A Study to Evaluate the Safety and Efficacy of PN20 in the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing an Elective Procedure

    Sponsor: Chongqing Peg-Bio Biopharm Co., Ltd.. Phase: PHASE1. Conditions: Thrombocytopenia Associated With Chronic Liver Disease

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07452497: Investigation of the Effect of Kinesiotape Application to the Surgical Area on Pain, Mobilization, Sleep, and Patient Satisfaction

    Sponsor: Busra Ercan. Phase: NA. Conditions: Intraoperative Complications

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05431010: Efficacy on Walking Ability of Electroacupuncture Therapy in Elderly Patients With Sarcopenia

    Sponsor: The Third Affiliated hospital of Zhejiang Chinese Medical University. Phase: NA. Conditions: Sarcopenia

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT01798810: Supplemental Perioperative Oxygen to Reduce Surgical Site Infection After High Energy Fracture Surgery

    Sponsor: Major Extremity Trauma Research Consortium. Phase: NA. Conditions: Post Operative Surgical Site Infection

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06843720: Expanding Access to Cervical Cancer Screening Through Primary HR-HPV Testing and Self-sampling: a Multicomponent Intervention for Safety Net Health Systems

    Sponsor: M.D. Anderson Cancer Center. Phase: NA. Conditions: HR-HPV Testing

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05006482: Geriatric Evaluation and Management With Survivorship Health Education for Older Survivors of Cancer, GEM-S Trial

    Sponsor: University of Rochester. Phase: PHASE3. Conditions: Lymphoma, Malignant Solid Neoplasm

    full page →ctgov ↗
    ›WITHDRAWNphase readoutNCT01536782: Optimal Tube Feeding Method in Head and Neck Cancer Patients

    Sponsor: Baylor Research Institute. Phase: NA. Conditions: Head and Neck Cancer

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT05389982: Mobile Health Platform for Surveillance of Kidney Stone

    Sponsor: Northwestern University. Phase: NA. Conditions: Stone, Kidney

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06426823: The Role of GIP in Postprandial Splanchnic Blood Flow Distribution and Metabolism in Patients With Type 2 Diabetes

    Sponsor: University of Copenhagen. Phase: NA. Conditions: Blood Flow

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05126823: Efficacy of a Combined ACT+ App Intervention to Improve Psychological Flexibility and Associated Symptoms in Cancer Patients

    Sponsor: Francisco Garcia Torres. Phase: NA. Conditions: Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06980259: Spatially Fractionated Radiotherapy Versus Conventional Radiotherapy in the Treatment of Soft Tissue Sarcoma

    Sponsor: Shandong Cancer Hospital and Institute. Phase: NA. Conditions: Soft Tissue Sarcoma (STS)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06724159: Observational Study of the Effectiveness of Funded Drugs for Genitourinary Tumors.

    Sponsor: Spanish Oncology Genito-Urinary Group. Phase: . Conditions: Genitourinary Cancers

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06645080: Vision Screening in Hospitals for Older Adults Following a Fall

    Sponsor: University of Nottingham. Phase: . Conditions: Falls, Vision; Disorder, Loss

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06256146: Investigating Modified Protocols of Oral Immunotherapy to Validate Efficacy and Safety

    Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre. Phase: NA. Conditions: Peanut Allergy, Milk Allergy, Cow's, Egg Allergy

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06830746: ASCEND CSP IDE Study

    Sponsor: Abbott Medical Devices. Phase: NA. Conditions: Heart Failure, Ventricular Arrythmia

    full page →ctgov ↗
    ›WITHHELDphase readoutNCT07223788: [Trial of device that is not approved or cleared by the U.S. FDA]

    Sponsor: [Redacted]. Phase: . Conditions:

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06941727: Relationship Between Mouth Opening and Masseter Elasticity in Oral Cancer

    Sponsor: National Taiwan University Hospital. Phase: . Conditions: Oral Cancer

    full page →ctgov ↗
    ›WITHDRAWNphase readoutNCT07550361: Validation of Non-Invasive Intracranial Pressure Estimation Using CPMX3 in the Periorbital Vein: A Feasibility Study in Pediatric Patients

    Sponsor: Compremium AG. Phase: NA. Conditions: Intracranial Pressure

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04739761: A Study of T-DXd in Participants With or Without Brain Metastasis Who Have Previously Treated Advanced or Metastatic HER2 Positive Breast Cancer

    Sponsor: AstraZeneca. Phase: PHASE3. Conditions: Breast Cancer

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04004442: Avelumab in Combination With AVB-S6-500 in Patients With Advanced Urothelial Carcinoma

    Sponsor: University of Oklahoma. Phase: PHASE1. Conditions: Urothelial Carcinoma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06441942: Prospective Multicenter Registry of Gender, Diversity and Inclusion (GEDI) of Women With Acute Coronary Syndrome

    Sponsor: IRCCS San Raffaele. Phase: . Conditions: Acute Coronary Syndrome, Gender, Genetic Predisposition

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05703386: Imaging the Pathogenesis of Cerebral Small Vessel Disease

    Sponsor: Johns Hopkins University. Phase: . Conditions: Ischemic Stroke, Hypertension, Hyperlipidemias, Diabetes

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05832086: Intermittent Fasting Using a Fasting-Mimicking Diet to Improve Prostate Cancer Control and Metabolic Outcomes

    Sponsor: Stephen Freedland. Phase: PHASE2. Conditions: Prostate Adenocarcinoma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07540286: A Cohort Study on the Safety and Efficacy of XH-02 in Treating Hypoparathyroidism

    Sponsor: Peking Union Medical College Hospital. Phase: PHASE2. Conditions: Hypoparathyroidism

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07312786: Testing the Feasibility of a Virtual Application to Support Breast and Colorectal Cancer Survivors

    Sponsor: Nova Scotia Health Authority. Phase: NA. Conditions: Breast Cancer Survivor, Colorectal Cancer Survivors

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05760885: Multisensory Augmentation for Post-stroke Standing Balance

    Sponsor: VA Office of Research and Development. Phase: EARLY_PHASE1. Conditions: Stroke

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05016843: The Study of Internet-delivered, Transdiagnostic Treatments for Anxiety and Depression

    Sponsor: Stockholm University. Phase: NA. Conditions: Anxiety Disorders, Depression

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07528326: The TRICURE US IDE Pivotal Study

    Sponsor: TRiCares. Phase: NA. Conditions: Tricuspid Regurgitation (TR)

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07442526: AGECTO Study: PCI vs. Optimal Medical Therapy for CTO in the Octogenarian Patients

    Sponsor: San Luigi Gonzaga Hospital. Phase: . Conditions: Coronary Artery Disease (CAD), Chronic Total Occlusion (CTO), Percutaneous Coronary Intervention (PCI), Optimal Medical Therapy

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06864026: A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)

    Sponsor: Eli Lilly and Company. Phase: PHASE4. Conditions: Psoriatic Arthritis, Overweight or Obesity

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07463443: Effectiveness of Chatbot for Improving Caregiving Outcomes in Primary Caregivers of Geriatric Pneumonia Patients: A Study on Knowledge, Attitude and Practice.

    Sponsor: Taipei Veterans General Hospital, Taiwan. Phase: NA. Conditions: Pneumonia, Family Caregivers, Knowledge, Attitudes, Practice, Chatbot, Geriatric Patient

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06648226: Food Swaps to Improve the Healthfulness and Reduce the Carbon Footprint of Grocery Purchases

    Sponsor: Stanford University. Phase: NA. Conditions: Food Selection, Nutrition, Food Preferences, Dietary Habits, Sustainability, Healthy Diet

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07586917: Optimizing Pregnancy and Treatment Interventions for Moms 3.0

    Sponsor: University of Utah. Phase: NA. Conditions: Opioid Abuse (Disorder), Stimulant Use Disorders

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07269340: Mandala Painting During Chemotherapy

    Sponsor: Uludag University. Phase: NA. Conditions: Mandala Painting, Chemotherapy, Vomiting, Anxiety, Comfort, Nursing Care

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07379489: Adjuvant Anti-PD-1 Therapy in Resected Hepatocellular Carcinoma

    Sponsor: Tongji Hospital. Phase: . Conditions: HCC, Adjuvant Therapy, Recurrence, Immune Checkpoint Inhibitor

    full page →ctgov ↗
    ← prev
    page 59 of 102
    next →